HIV Diagnosis Market

HIV Diagnosis Market Size by Type (Consumables, Instruments, Software and Services), Technology (Antibody Test, Viral Load Tests, CD4 Tests, Tests for Early Infant Diagnosis, Tests for Viral Identification), End Use, Regions, Global Industry Analysis, Share, Growth, Trends, and Forecast 2021 to 2028

Base Year: 2020 Historical Data: 2018-19
  • Report ID: TBI-12557
  • Published Date: Oct, 2021
  • Pages: 239
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global HIV diagnosis market is expected to reach USD 6.45 billion by 2028, at a CAGR of 12.35% during the forecast period 2021-2028. Increasing prevalence of HIV/AIDS across the globe is one of the major factors driving the growth of market.

Market Overview:

HIV stands for human immunodeficiency virus, which causes AIDS (acquired immunodeficiency syndrome). The Centers for Disease Control and Prevention (CDC) recommends that people in between age 13 to 64 should get tested for HIV at least once as part of a routine health test. The HIV diagnosis refers to the method for detection of the virus in the body. Blood tests are the most common way to detect and diagnose HIV. Generally, tests are done for the reason including individual diagnosis, protection of blood or tissue products safety, and public health surveillance. Early diagnosis of HIV is very important to prevent the further transmission of the disease and to begin the therapy.

There are three types of tests used to diagnose HIV infection. Antibody test, antigen/antibody test and NATs are some of the test used for the HIV diagnosis. The antibody test is usually used for the initial testing of HIV, while NATs are very expensive and cannot be used routinely until the person had high-risk exposure. HIV infection across the globe continue to be the major public health crisis. Thus, HIV diagnosis has become increasingly important to prevent further transmission of the disease. ELISA test, which stands for enzyme-linked immunosorbent assay, is one of the most common tests which is used to diagnose the HIV infection. When ELISA test detects the positive infection, the Western blot test is usually carried out to confirm the diagnosis. Hone test is also available for the diagnosis of HIV. Home Access Express Test, which is sold in pharmacies, is the only test approved by the U.S. Food and Drug Administration for the home HIV test.

Get an overview of this study by requesting a free sample

Market Dynamics:

Drivers:
  • Increasing prevalence of HIV/AIDS across the globe

HIV prevalence is increasing rapidly in almost every geographic region and becoming one of the major public health crisis in the world. As per the U.S. Department of Health & Human Service data, there were about 37.9 million people across the globe with HIV/AIDS. Approximately 1.7 million individuals in the world are newly infected in the year 2018. Around 79% of total infected people are aware of their HIV infection, and 21% of people are still needed to access the HIV testing service. Therefore, increasing prevalence of HIV/AIDS across the globe driving the growth of the market.

  • Rising government initiative to prevent the HIV transmission

The increasing various government initiative to prevent the further transmission of HIV is one of the key factor driving the demand for HIV diagnosis. Many governments across the globe are working hard to eradicate HIV/AIDS, which possess the serious public health risk. Efforts are now being made to bring down the HIV cases to zero. Thus, many governments are introducing new programs, diagnosis, and treatment for HIV/AIDS. 

Restraints:
  • High cost of nucleic acid test(NAT) HIV diagnosis

A nucleic acid test (NAT) tests looked for the actual testing of the virus in the blood rather than the antibodies. However, this test is very expensive and not used routinely for the HIV diagnosis. It used when the person had exposed to the high risk and have the early symptoms of HIV/AIDS. Thus, the high cost of NAT HIV diagnosis may hamper the growth of the market over the forecast period. 

Opportunities:
  • Increasing use of home test kits for the HIV diagnosis

The diagnosis of HIV has been changed enormously from the past few years. The home test kits make it possible for the individual to access the kit at the pharmacies and to check the HIV infection at home. The home test kit has increased the convenience for the people and also helps to maintain their privacy. Thus, increasing the use of home test kit for the HIV diagnosis will provide further growth opportunities in the market.

Challenges:
  • Lack of testing centers in the underdeveloped countries

East and southern Africa are one of the most highly affected regions for HIV/AIDS. However, there are not enough testing centres available for the diagnosis of HIV. In addition to this, many people still not aware of their HIV status, due to lack of awareness. In addition to this, many underdeveloped countries do not have enough laboratories and skilled professionals for the testing and diagnosis of HIV, which is hampering the growth of the market over the forecast period.

Segmentation Analysis:

The global HIV diagnosis market has been segmented based on type, technology, end use, and regions.

  • The type segment is divided into consumables, instrument, and software and services. The consumable segment accounted for the major market share in the global HIV diagnosis market and held the market share of 56.57% in the year 2020. The consumable segment contains the assays, reagents, and kits for the HIV diagnosis. These kit are the complete package for the detection and diagnosis of the HIV test. Thus, increasing usage of consumables driving the growth of the market.
  • The technology segment includes antibody test, viral load tests, CD4 tests, tests for early infant diagnosis, and tests for viral identification. The antibody test segment dominated the global market and held a market share of 39.36% in the year 2020. The antibody test is further classified into HIV-1 Screening Tests, HIV-1 antibody confirmatory test and HIV-2 & group O test. The antibody test is commonly used for the initial screening of HIV detection. It is the most widely used test across the globe, which is boosting the growth of the market.
  • The end-use segment includes diagnostic laboratories, hospitals, blood banks, home care settings, others. The home care setting is projected to grow at the highest CAGR of 12.9% over the forecast period. The growth is mainly due to increasing preference for the home test kits for the HIV diagnosis to maintain privacy.
Regional Segmentation Analysis:

The regions analyzed for the global HIV diagnosis market include North America, Europe, South America, Asia Pacific, and the Middle East and Africa. The North America region accounted for the major market share of 39.71% in the year 2020.

  • The growth is mainly due to the increasing prevalence of HIV in the region. The U.S. accounted for the largest market share in the North America region. This is mainly due to owing to a large number of cases in the country. For instance, according to the data by the Center for the Disease Control and Prevention, approximately 1.1 million people had HIV at the end of the year 2016. Thus, increasing government initiative to prevent further cases of HIV driving the growth of the market in the North America region.
  • The Asia Pacific region projected to grow at the highest CAGR of 12.8% over the forecast period. The growth is owing to increasing awareness about HIV/ AIDS in countries such as India, China, and many Southeast Asian countries. Currently, India has a total of 2.1 million HIV cases. The government of India are taking several measures to eradicate HIV from India. Thus, increasing healthcare spending and rising awareness are driving the growth of the market in the Asia Pacific region.

North America HIV Diagnosis Market Share in 2020- 39.71%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Competitive Analysis:

The key players of global HIV diagnosis market are majorly focusing on adoption of various strategies such as new product development, joint venture, collaboration, technological integration, product innovations, mergers & acquisitions, and partnerships to gain the significant market share in the industry.

In July 2018, Abbott Healthcare announced the launch of m-PIMA HIV-1/2 VL, the first viral load point-of-care test for the fast, accurate and easy-to-use test to manage HIV.

In March 2020, Johnson & Johnson’s company, The Janssen Pharmaceutical Companies announced that Health Canada has approved CABENUVA (an injectable suspensions), for the treatment of HIV-1 infection in adults.

List of Key Market Players:

  • Alere Inc.
  • Abbott Healthcare
  • Abbvie Inc.
  • Bristol-Myers Squibb
  • Janssen Therapeutics
  • Gilead Sciences
  • Merck & Co. Inc.
  • BD Biosciences
  • Beckman Coulter
  • Partec
  • Sysmex
  • PointCare Technologies Inc.
  • ZyomyxInc
  • Mylaninc.
  • Roche Diagnostics
  • Siemens Healthcare
  • Qiagen
  • bioMerieux

Key Target Audience

  • Government Bodies
  • Investors/Shareholders
  • Regulatory bodies
  • World Health organization
  • Pharmaceutical Companies
  • Vendors of kits and Instruments

Report Description:

  • Global HIV diagnosisMarket, Industry Analysis, Trends, Analysis and Forecast, 2020 to 2028 is a forthcoming/imminent research report which is to be published by The Brainy Insights.
  • 2020 is considered as the base year of the report. 2017 and 2018 are considered as the historic years and 2020 to 2028 are the forecast years. The global HIV diagnosis market is based on revenue (USD Million/Billion). The report incorporates the market study on the basis of revenue. The study covers the market share revenue/market share for each of the segments, regions and countries catering to global HIV diagnosis market. The regions analyzed for the market are Europe, Asia Pacific, North America, South America and Middle East & Africa. Furthermore, the regions are further analyzed at the country level.
  • The report encompasses with the relative data & information, which have been validated by the leading industry professionals and experts all across the globe. The research report also delivers an outline of the attractiveness of HIV diagnosis and regions which are deduced and formulated on the basis of their growth rate (CAGR), market size, and attractiveness by analyzing the present and future prospects to market growth and development in future.
  • The report illustrates the detailed (both quantitative and qualitative) analysis of historical data, revenues, key developments, along with the crucial strategies adopted by key organizations catering to global HIV diagnosis market. This offers vital and in depth insights in order to depict the overall market scenario.
  • The report offers the detailed study for the company profiles of key organizations operating in the global HIV diagnosis market and a comparative assessment based on their product offering, business overviews, geographic presence, business strategies, segment market share, product development &innovations, recent developments, joint venture, partnerships,mergers & acquisitions, strategic alliances, SWOT analysis, and key financial information. This helps in evaluating the overall competition present in the market scenario. 
  • The report provides an elaborative assessment of the porter’s five forces analysis coupled with SWOT analysis so as to provide business related data and information’s. Porter’s five forces model is analyzed to understand the overall competitive scenario that is prevailing in the market. Additionally, the SWOT analysis identifies both the positive and negative attributes of the market development which influences the company growth and development in order to sustain and survive in the long run.
  • Along with that, the report also focuses on the market related driving factors, growth limitations (restraints), potential industry opportunities, significant trends and development which act as a key potential for the investors. 
  • Potential growth prospects along with the penetration rate analysis of the products (market related i.e., global HIV diagnosis market is covered in order to comprehend the adoption rate and evaluate the market size.

Frequesntly Asked Questions

As per The Brainy Insights, the size of the HIV Diagnosis market was valued at USD 2.59 billion in 2020 and is anticipated to reach USD 6.45 billion by 2028.

Global HIV Diagnosis market is growing at a CAGR of 12.35% during the forecast period 2021-2028.

The global HIV Diagnosis market has been segmented based on type, technology, end use, and regions. The consumables segment dominated the global market and held the largest market share in the year 2020.

The North America region emerged as the largest market for the HIV Diagnosis.

Increasing prevalence of HIV/AIDS across the globe is one of the significant driving factor for the growth of HIV diagnosis market.

High cost of HIV/AIDS diagnosis may hamper the growth of the market over the forecast period.

Increasing usage of home based test kits is expected to offer the future growth opportunity in the market.

Key players are Alere Inc., Abbott Healthcare, Abbvie Inc., Bristol-Myers Squibb, Janssen Therapeutics, Gilead Sciences, Merck & Co. Inc, BD Biosciences, Beckman Coulter, Partec, among others.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis By Type
          4.3.2. Market Attractiveness Analysis By Technology
          4.3.3. Market Attractiveness Analysis By End Use
          4.3.4. Market Attractiveness Analysis By Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. Increasing prevalence of HIV/AIDS across the globe
          5.2.2. Rising government initiative to prevent the HIV transmission
    5.3. Restrains
          5.3.1. High cost of nucleic acid test (NAT) HIV diagnosis
    5.4. Opportunities
          5.4.1. Increasing use of home test kits for the HIV diagnosis
    5.5. Challenges
          5.5.1. Lack of testing centers in the underdeveloped countries

6. Global HIV Diagnosis Market Analysis and Forecast, By Product
    6.1. Segment Overview
    6.2. Consumables
    6.3. Instrument
    6.4. Software And Services

7. Global HIV Diagnosis Market Analysis and Forecast, By Technology
    7.1. Segment Overview
    7.2. Antibody Test
    7.3. Viral Load Tests
    7.4. CD4 Tests
    7.5. Tests For Early Infant Diagnosis
    7.6. Tests For Viral Identification

8. Global HIV Diagnosis Market Analysis and Forecast, By End Use
    8.1. Segment Overview
    8.2. Diagnostic Laboratories
    8.3. Hospitals
    8.4. Blood Banks
    8.5. Home Care Settings
    8.6. Others

9. Global HIV Diagnosis Market Analysis and Forecast, By Regional Analysis
    9.1. Segment Overview
    9.2. North America
          9.2.1. U.S.
          9.2.2. Canada
          9.2.3. Mexico
    9.3. Europe
          9.3.1. Germany
          9.3.2. France
          9.3.3. U.K.
          9.3.4. Italy
          9.3.5. Spain
    9.4. Asia-Pacific
          9.4.1. Japan
          9.4.2. China
          9.4.3. India
    9.5. South America
          9.5.1. Brazil
    9.6. Middle East and Africa
          9.6.1. UAE
          9.6.2. South Africa

10. Global HIV Diagnosis Market-Competitive Landscape
    10.1. Overview
    10.2. Market Share of Key Players in the HIV Diagnosis Market
          10.2.1. Global Company Market Share
          10.2.2. North America Company Market Share
          10.2.3. Europe Company Market Share
          10.2.4. APAC Company Market Share
    10.3. Competitive Situations and Trends
          10.3.1. Product Launches and Developments
          10.3.2. Partnerships, Collaborations, and Agreements
          10.3.3. Mergers & Acquisitions
          10.3.4. Expansions

11. Company Profiles
    11.1. Abbott Healthcare
          11.1.1. Business Overview
          11.1.2. Company Snapshot
          11.1.3. Company Market Share Analysis
          11.1.4. Company Product Portfolio
          11.1.5. Recent Developments
          11.1.6. SWOT Analysis
    11.2. Alere Inc.
          11.2.1. Business Overview
          11.2.2. Company Snapshot
          11.2.3. Company Market Share Analysis
          11.2.4. Company Product Portfolio
          11.2.5. Recent Developments
          11.2.6. SWOT Analysis
    11.3. Abbvie Inc.
          11.3.1. Business Overview
          11.3.2. Company Snapshot
          11.3.3. Company Market Share Analysis
          11.3.4. Company Product Portfolio
          11.3.5. Recent Developments
          11.3.6. SWOT Analysis
    11.4. Bristol-Myers Squibb
          11.4.1. Business Overview
          11.4.2. Company Snapshot
          11.4.3. Company Market Share Analysis
          11.4.4. Company Product Portfolio
          11.4.5. Recent Developments
          11.4.6. SWOT Analysis
    11.5. Janssen Therapeutics
          11.5.1. Business Overview
          11.5.2. Company Snapshot
          11.5.3. Company Market Share Analysis
          11.5.4. Company Product Portfolio
          11.5.5. Recent Developments
          11.5.6. SWOT Analysis
    11.6. Gilead Sciences
          11.6.1. Business Overview
          11.6.2. Company Snapshot
          11.6.3. Company Market Share Analysis
          11.6.4. Company Product Portfolio
          11.6.5. Recent Developments
          11.6.6. SWOT Analysis
    11.7. Merck & Co. Inc
          11.7.1. Business Overview
          11.7.2. Company Snapshot
          11.7.3. Company Market Share Analysis
          11.7.4. Company Product Portfolio
          11.7.5. Recent Developments
          11.7.6. SWOT Analysis
    11.8. BD Biosciences
          11.8.1. Business Overview
          11.8.2. Company Snapshot
          11.8.3. Company Market Share Analysis
          11.8.4. Company Product Portfolio
          11.8.5. Recent Developments
          11.8.6. SWOT Analysis
    11.9. Beckman Coulter
          11.9.1. Business Overview
          11.9.2. Company Snapshot
          11.9.3. Company Market Share Analysis
          11.9.4. Company Product Portfolio
          11.9.5. Recent Developments
          11.9.6. SWOT Analysis
    11.10. Partec
          11.10.1. Business Overview
          11.10.2. Company Snapshot
          11.10.3. Company Market Share Analysis
          11.10.4. Company Product Portfolio
          11.10.5. Recent Developments
          11.10.6. SWOT Analysis
 

List of Table

1.Global HIV Diagnosis Market, By Product, 2018–2028  (USD Billion)

2.Global Consumables, HIV Diagnosis Market, By Region, 2018–2028 (USD Billion)

3.Global Instruments, HIV Diagnosis Market, By Region, 2018–2028 (USD Billion)

4.Global Software & Services, HIV Diagnosis Market, By Region, 2018–2028 (USD Billion)

5.Global HIV Diagnosis Market, By Technology, 2018–2028 (USD Billion)

6.Global Antibody Test HIV Diagnosis Market, By Region, 2018–2028 (USD Billion)

7.Global Viral Load Test HIV Diagnosis Market, By Region, 2018–2028 (USD Billion)

8.Global CD4 Test HIV Diagnosis Market, By Region, 2018–2028 (USD Billion)

9.Global Test For Early Infant Diagnosis HIV Diagnosis Market, By Region, 2018–2028 (USD Billion)

10.Global Viral Identification HIV Diagnosis Market, By Region, 2018–2028 (USD Billion)

11.Global HIV Diagnosis Market, By End Use, 2018–2028 (USD Billion)

12.Global Hospitals, HIV Diagnosis Market, By Region, 2018–2028 (USD Billion)

13.Global Diagnostics laboratories, HIV Diagnosis Market, By Region, 2018–2028 (USD Billion)

14.Global Blood Bank, HIV Diagnosis Market, By Region, 2018–2028 (USD Billion)

15.Global Home Care Settings HIV Diagnosis Market, By Region, 2018–2028 (USD Billion)

16.Global Others HIV Diagnosis Market, By Region, 2018–2028 (USD Billion)

17.Global HIV Diagnosis Market, By Region, 2018–2028 (USD Billion)

18.North America HIV Diagnosis Market, By Product, 2018–2028 (USD Billion)

19.North America HIV Diagnosis Market, By Technology, 2018–2028 (USD Billion)

20.North America HIV Diagnosis Market, By End Use, 2018–2028 (USD Billion)

21.U.S. HIV Diagnosis Market, By Product, 2018–2028 (USD Billion)

22.U.S. HIV Diagnosis Market, By Technology, 2018–2028 (USD Billion)

23.U.S. HIV Diagnosis Market, By End Use, 2018–2028 (USD Billion)

24.Canada HIV Diagnosis Market, By Product, 2018–2028 (USD Billion)

25.Canada HIV Diagnosis Market, By Technology, 2018–2028 (USD Billion)

26.Canada HIV Diagnosis Market, By End Use, 2018–2028 (USD Billion)

27.Mexico HIV Diagnosis Market, By Product, 2018–2028 (USD Billion)

28.Mexico HIV Diagnosis Market, By Technology, 2018–2028 (USD Billion)

29.Mexico HIV Diagnosis Market, By End Use, 2018–2028 (USD Billion)

30.Europe HIV Diagnosis Market, By Product, 2018–2028 (USD Billion)

31.Europe HIV Diagnosis Market, By Technology, 2018–2028 (USD Billion)

32.Europe HIV Diagnosis Market, By End Use, 2018–2028 (USD Billion)

33.Germany HIV Diagnosis Market, By Product, 2018–2028 (USD Billion)

34.Germany HIV Diagnosis Market, By Technology, 2018–2028 (USD Billion)

35.Germany HIV Diagnosis Market, By End Use, 2018–2028 (USD Billion)

36.France HIV Diagnosis Market, By Product, 2018–2028 (USD Billion)

37.France HIV Diagnosis Market, By Technology, 2018–2028 (USD Billion)

38.France HIV Diagnosis Market, By End Use, 2018–2028 (USD Billion)

39.U.K. HIV Diagnosis Market, By Product, 2018–2028 (USD Billion)

40.U.K. HIV Diagnosis Market, By Technology, 2018–2028 (USD Billion)

41.U.K. HIV Diagnosis Market, By End Use, 2018–2028 (USD Billion)

42.Italy HIV Diagnosis Market, By Product, 2018–2028 (USD Billion)

43.Italy HIV Diagnosis Market, By Technology, 2018–2028 (USD Billion)

44.Italy HIV Diagnosis Market, By End Use, 2018–2028 (USD Billion)

45.Spain HIV Diagnosis Market, By Product, 2018–2028 (USD Billion)

46.Spain HIV Diagnosis Market, By Technology, 2018–2028 (USD Billion)

47.Spain HIV Diagnosis Market, By End Use, 2018–2028 (USD Billion)

48.Asia Pacific HIV Diagnosis Market, By Product, 2018–2028 (USD Billion)

49.Asia Pacific HIV Diagnosis Market, By Technology, 2018–2028 (USD Billion)

50.Asia Pacific HIV Diagnosis Market, By End Use, 2018–2028 (USD Billion)

51.Japan HIV Diagnosis Market, By Product, 2018–2028 (USD Billion)

52.Japan HIV Diagnosis Market, By Technology, 2018–2028 (USD Billion)

53.Japan HIV Diagnosis Market, By End Use, 2018–2028 (USD Billion)

54.China HIV Diagnosis Market, By Product, 2018–2028 (USD Billion)

55.China HIV Diagnosis Market, By Technology, 2018–2028 (USD Billion)

56.China HIV Diagnosis Market, By End Use, 2018–2028 (USD Billion)

57.India HIV Diagnosis Market, By Product, 2018–2028 (USD Billion)

58.India HIV Diagnosis Market, By Technology, 2018–2028 (USD Billion)

59.India HIV Diagnosis Market, By End Use, 2018–2028 (USD Billion)

60.South America HIV Diagnosis Market, By Product, 2018–2028 (USD Billion)

61.South America HIV Diagnosis Market, By Technology, 2018–2028 (USD Billion)

62.South America HIV Diagnosis Market, By End Use, 2018–2028 (USD Billion)

63.Brazil HIV Diagnosis Market, By Product, 2018–2028 (USD Billion)

64.Brazil HIV Diagnosis Market, By Technology, 2018–2028 (USD Billion)

65.Brazil HIV Diagnosis Market, By End Use, 2018–2028 (USD Billion)

66.Middle East and Africa HIV Diagnosis Market, By Product, 2018–2028 (USD Billion)

67.Middle East and Africa HIV Diagnosis Market, By Technology, 2018–2028 (USD Billion)

68.Middle East and Africa HIV Diagnosis Market, By End Use, 2018–2028 (USD Billion)

69.UAE HIV Diagnosis Market, By Product, 2018–2028 (USD Billion)

70.UAE HIV Diagnosis Market, By Technology, 2018–2028 (USD Billion)

71.UAE HIV Diagnosis Market, By End Use, 2018–2028 (USD Billion)

72.South Africa HIV Diagnosis Market, By Product, 2018–2028 (USD Billion)

73.South Africa HIV Diagnosis Market, By Technology, 2018–2028 (USD Billion)

74.South Africa HIV Diagnosis Market, By End Use, 2018–2028 (USD Billion)

List of Figures 

1.Global HIV Diagnosis Market Segmentation

2.HIV Diagnosis Market: Research Methodology

3.Market Size Estimation Methodology: Bottom-Up Approach

4.Market Size Estimation Methodology: Top-Down Approach

5.Data Triangulation

6.Porter’s Five Forces Analysis

7.Value Chain Analysis

8.Global HIV Diagnosis Market Attractiveness Analysis By Product

9.Global HIV Diagnosis Market Attractiveness Analysis By Technology

10.Global HIV Diagnosis Market Attractiveness Analysis By End Use

11.Global HIV Diagnosis Market Attractiveness Analysis By Region

12.Global HIV Diagnosis Market: Dynamics

13.Global HIV Diagnosis Market Share By Product(2021 & 2028)

14.Global HIV Diagnosis Market Share By Technology(2021 & 2028)

15.Global HIV Diagnosis Market Share By End Use(2021 & 2028)

16.Global HIV Diagnosis Market Share by Regions (2021 & 2028)

17.Global HIV Diagnosis Market Share by Company (2020)

This study forecasts revenue and volume growth at global, regional, and country levels from 2018 to 2028. The Brainy Insights has segmented the global HIV diagnosis market on the basis of below mentioned segments:

Global HIV Diagnosis Market by Product:

  • Consumables
  • Instruments
  • Software & Services

Global HIV Diagnosis Market by Technology:

  • Antibody Tests
    • HIV-1 Screening Tests
      • ELISA
      • Rapid Tests
      • Home Access Dried Blood Spot
    • HIV-1 Confirmatory Tests
      • Western Blot Tests
      • Indirect Immune Fluorescent Antibody Assays (IFA)
      • Line Immunoassays (LIA)
      • Radio-Immunoprecipitation Assays (RIPA)
    • HIV-2 & Group O Diagnostic Tests
  • Viral Load Tests
  • CD4 Tests
  • Tests for Early Infant Diagnosis
  • Tests for Viral Identification

Global HIV Diagnosis Market by End Use:

  • Diagnostic laboratories
  • Hospitals
  • Blood Banks
  • Home care settings
  • Others

Global HIV Diagnosis Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date